Press releases
- Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
- Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
- Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
- Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
Key statistics
On Friday, Omeros Corp (3O8:DUS) closed at 2.92, 193.82% above the 52 week low of 0.9945 set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.81 |
---|---|
High | 2.92 |
Low | 2.81 |
Bid | 2.90 |
Offer | 2.98 |
Previous close | 2.80 |
Average volume | 12.00 |
---|---|
Shares outstanding | 57.94m |
Free float | 55.41m |
P/E (TTM) | -- |
Market cap | 177.30m USD |
EPS (TTM) | -2.79 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 18:30 BST.
More ▼